Long-acting methylphenidate for the treatment of adults with attention deficit hyperactivity disorder

被引：0
|
作者：
Asherson, P
Libretto, SE
机构：
[1] Janssen Cilag Ltd, High Wycombe HP14 4HJ, Bucks, England
[2] Inst Psychiat, MRC, Social Genet Dev Psychiat Ctr, London SE5 8AF, England
来源：
BRITISH JOURNAL OF DEVELOPMENTAL DISABILITIES | 2004年 / 50卷 / 99期
关键词：
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：143 / 151
页数：9
相关论文
共 50 条
  • [11] A Prospective Open-label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder
    Joshi, Gagan
    DiSalvo, Maura
    Ceranoglu, T. Atilla
    Wozniak, Janet
    Galdo, Maribel
    Hoskova, Barbora
    Dallenbach, Nina
    Castle, Rose
    Biederman, Joseph
    NEUROLOGY, 2019, 92 (15)
  • [12] The Impact of Long-Acting Medications on Attention-Deficit/Hyperactivity Disorder Treatment Disparities
    Saloner, Brendan
    Fullerton, Catherine
    McGuire, Thomas
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (06) : 401 - 409
  • [13] Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    David Coghill
    Tobias Banaschewski
    Alessandro Zuddas
    Antonio Pelaz
    Antonella Gagliano
    Manfred Doepfner
    BMC Psychiatry, 13
  • [14] Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    Coghill, David
    Banaschewski, Tobias
    Zuddas, Alessandro
    Pelaz, Antonio
    Gagliano, Antonella
    Doepfner, Manfred
    BMC PSYCHIATRY, 2013, 13
  • [15] OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
    Antoni Ramos-Quiroga, J.
    Corominas, Margarida
    Castells, Xavier
    Bosch, Rosa
    Casas, Miguel
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1121 - 1131
  • [16] Long-Acting Methylphenidate Reduces Collision Rates of Young Adult Drivers With Attention-Deficit/Hyperactivity Disorder
    Cox, Daniel J.
    Davis, Margaret
    Mikami, Amori Yee
    Singh, Harsimran
    Merkel, Richard L.
    Burket, Roger
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) : 225 - 230
  • [17] Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder
    Olfson, Mark
    Marcus, Steven C.
    Zhang, Huabin F.
    Wan, George J.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (07): : 570 - 577
  • [18] The use of methylphenidate in adults - Attention deficit disorder with hyperactivity
    Gauillard, J
    Castelnau, C
    VacheronTrystram, MN
    Cheref, S
    Caroli, F
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1997, 23 (04): : 251 - 256
  • [19] Methylphenidate in adults with attention-deficit/hyperactivity disorder
    Koesters, M.
    Weinmann, S.
    Becker, T.
    NERVENARZT, 2007, 78 (09): : 1065 - 1066
  • [20] Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    David Coghill
    Tobias Banaschewski
    Alessandro Zuddas
    Antonio Pelaz
    Antonella Gagliano
    Manfred Doepfner
    BMC Psychiatry, 15
12345